- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Vulvar Intraepithelial Neoplasia Grade 2 in Singapore
Total 11 results
-
Singapore General HospitalNational Neuroscience InstituteTerminated
-
Shandong UniversityNational University Hospital, Singapore; Prince of Wales Hospital, Shatin,... and other collaboratorsUnknownGastric Carcinoma | Gastric Intestinal Metaplasia | Gastric Intraepithelial NeoplasiaSingapore, Australia, China
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome, High GradeSingapore
-
National Cancer Centre, SingaporeCompletedHER 2 Positive Advanced Gastric CancerSingapore
-
Day One Biopharmaceuticals, Inc.Pacific Pediatric Neuro-Oncology ConsortiumRecruitingAdvanced Solid Tumor | Low-grade GliomaUnited States, Israel, Korea, Republic of, Denmark, Singapore, Netherlands, Canada, Australia, Germany, Switzerland, United Kingdom
-
Day One Biopharmaceuticals, Inc.SIOPe Brain Tumor Group LOGGIC ConsortiumRecruitingLow-grade GliomaUnited States, Korea, Republic of, France, Germany, Spain, United Kingdom, Belgium, Denmark, Canada, Italy, Finland, Australia, Ireland, Switzerland, Netherlands, Czechia, Greece, New Zealand, Slovenia, Sweden, Hungary, Singapore, A... and more
-
Al-Azhar UniversityHelwan University; National Liver Institute, EgyptCompletedCOVID-19 | Cholangiocarcinoma | SARS-CoV-2 | Pancreas Cancer | Obstructive Jaundice | Cholangitis, Secondary BiliarySingapore, Germany, United States, Egypt, Peru
-
Merck Sharp & Dohme LLCActive, not recruitingOvarian Carcinoma | High-grade Serous Ovarian CarcinomaKorea, Republic of, Spain, Poland, United States, Belgium, Canada, Chile, Israel, Italy, Singapore, Taiwan
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
GenmabAbbVieActive, not recruitingSmall Lymphocytic Lymphoma (SLL) | DLBCL | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | MCL | Marginal Zone Lymphoma (MZL) | High-grade B-cell Lymphoma (HGBCL) | FLKorea, Republic of, United States, Australia, Singapore, Netherlands, Sweden, France, Finland, United Kingdom, Spain, Germany, Denmark, Italy, Poland, Canada